The FDA has approved the subcutaneous formulation of nivolumab (Opdivo). This approval makes it the first and only subcutaneously administered PD-1 inhibitor. Subcutaneous nivolumab is approved in all ...
The FDA has issued a complete response letter to Johnson & Johnson for the subcutaneous version of its lung cancer drug Rybrevant after issues were … ...
Attention was paid to protecting the subcutaneous blood ... Doppler color ultrasound, CT imaging, etc., and initially suggested a giant mesial tissue tumor of the armpit; we performed complete ...
A lipoma is a lump under the skin that occurs due to an overgrowth of fat cells. Lipomas are typically harmless but people may wish to remove one that causes pain, complications, or other symptoms ...